Immunohistochemical and immunofluorescence analyses revealed increased infiltration of CD8+ T cells in tetrandrine-treated tumors, indicating an enhanced immune response within the tumor microenvironment (Fig. 7d, e). The gene discussed is CD8A; the disease is neoplasm.